Contact this trialFirst, we need to learn more about you.
BGB-30813 + Tislelizumab for Cancer
Recruiting1 awardPhase 1
Hackensack, New Jersey
This trial is testing a new drug, BGB-30813, to treat patients with advanced cancer. The goal is to see if this drug can safely help stop or slow down the cancer. The study will find the best dose and check if the treatment improves patients' conditions.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service